Structure-based virtual high-throughput screening and molecular dynamics simulations for repurposing FDA-approved drugs as STAT3 inhibitors

Guangshuai Zhang, Yingyan Liao, Ziyu Tan, Qingqing Xie, Zishu Liu, Jin Xiao, Si Yan, Xiaoqian Guo, Rui Peng, Wei Luo, Shuanglin Qin
Current Pharmaceutical Analysis · Elsevier · 2026-11-01 · DOI: 10.1016/j.cpan.2026.11.003

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles